Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LINQ II™ Insertable Cardiac Monitor (LNQ22)

K-Number: K233320 · 2023-10-31

Decision Date2023-10-31
Product CodeMXD
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

LINQ II™ Insertable Cardiac Monitor (LNQ22) is a medical device manufactured by Medtronic, Inc.. It received FDA 510(k) clearance on 2023-10-31 under approval number K233320. The device is classified under product code MXD. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LINQ II™ Insertable Cardiac Monitor (LNQ22)?

LINQ II™ Insertable Cardiac Monitor (LNQ22) is a medical device that received FDA 510(k) clearance on 2023-10-31. It is manufactured by Medtronic, Inc.. The 510(k) number is K233320.

When was LINQ II™ Insertable Cardiac Monitor (LNQ22) approved by the FDA?

LINQ II™ Insertable Cardiac Monitor (LNQ22) received FDA 510(k) clearance on 2023-10-31, under approval number K233320.

What company makes LINQ II™ Insertable Cardiac Monitor (LNQ22)?

LINQ II™ Insertable Cardiac Monitor (LNQ22) is manufactured by Medtronic, Inc..

What is the FDA product code for LINQ II™ Insertable Cardiac Monitor (LNQ22)?

The FDA product code for LINQ II™ Insertable Cardiac Monitor (LNQ22) is MXD.

Related Clinical Trials

Other Devices by Medtronic, Inc.

View all 137 devices →

Related Devices (Code: MXD)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.